Egyptian International Pharmaceutical Industries financials at a glance

+ Portfolio

The revenue of Egyptian International Pharmaceutical Industries is reported as 5.23167 billion Pounds in the fiscal year 2023. The earnings were 5.98 Pounds per share in 2023, which was 0.67 higher than 2022. And about 0.82578 billion Pounds are reported as free cash flow in the financials of Egyptian International Pharmaceutical Industries 2023. Dividends of 1.5 Pounds per share were paid to shareholders of Egyptian International Pharmaceutical Industries stock CASE:PHAR in fiscal 2023.

£5.23B

Revenue

£5.98

Earnings Per Share

42.98%

Gross Margin %

£0.00M

Free Cash Flow

Revenue

5,231.67

Earnings Per Share

5.98

Gross Margin %

42.98

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Rev.	Revenue	N/A	£5.23B	£3.80B	£3.44B	£2.91B	£3.41B	£2.82B	£2.53B	£1.97B	£1.70B	£1.36B	£1.25B	£1.16B	£1.11B	£1.00B	£910.08M	£850.23M	£745.34M	£0.00M	£0.00M
GM %	Gross Margin %	41.57%	42.98%	39.40%	42.59%	41.78%	36.69%	28.45%	37.97%	37.80%	32.09%	32.47%	35.78%	39.46%	0.00%	0.00%	43.86%	41.34%	39.34%	41.66%	0.00%
OM	Operating Margin	20.67%	23.15%	16.74%	22.79%	20.18%	20.54%	23.97%	31.16%	30.70%	27.04%	26.73%	29.45%	33.01%	0.00%	0.00%	32.95%	33.80%	32.49%	30.59%	0.00%
EPS	Earnings Per Share	£5.84	£5.98	£5.94	£5.27	£4.91	£6.63	£8.87	£6.98	£3.96	£3.61	£3.02	£2.94	£3.40	£3.34	£2.88	£2.50	£2.31	£1.99	£1.64	£0.93
Div.	Dividends	N/A	£1.50	£0.00	£1.50	£2.95	£4.25	£3.39	£3.60	£2.80	£2.80	£2.40	£2.40	£2.40	£1.36	£1.53	£1.37	£1.20	£1.09	£0.95	£0.87
PR %	Payout Ratio %	0	25.08%	0	28.46%	60.08%	64.10%	38.22%	51.58%	70.71%	77.56%	79.47%	81.63%	70.59%	40.72%	53.13%	54.80%	51.95%	54.77%	57.93%	93.55%
Sha.	Shares	N/AM	148.76M	99.17M	99.17M	97.57M	99.17M	99.21M	99.21M	99.21M	99.21M	99.21M	99.21M	99.17M	99.17M	99.17M	99.17M	99.17M	99.17M	99.17M	99.17M
OCF	Operating Cash Flow	N/A	£860.50M	£-,380.94M	£383.82M	£164.86M	£280.30M	£-12.19M	£209.29M	£640.87M	£402.57M	£204.99M	£306.92M	£420.18M	£288.35M	£253.10M	£286.20M	£283.10M	£0.00M	£0.00M	£0.00M
FCF	Free Cash Flow	N/A	£825.78M	£-,943.01M	£-53.27M	£-38.70M	£103.18M	£-,141.94M	£125.16M	£518.09M	£280.24M	£791.05M	£177.48M	£232.09M	£81.25M	£0.00M	£0.00M	£0.00M	£0.00M	£0.00M	£0.00M
FCFS	Free Cash Flow Per Share	£-16.76	£-14.79	£-8.67	£-0.54	£-0.40	£1.04	£0.00	£1.26	£5.22	£2.82	£0.95	£1.79	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00	£0.00

Egyptian International Pharmaceutical Industries financials at a glance

Financials

Discover